Tadaflo 20 mg (Tadalafil)

Product Overview

n

Tadaflo 20 mg is a prescription medication manufactured by Cipla Limited. It contains the active ingredient Tadalafil, a phosphodiesterase‑5 (PDE‑5) inhibitor. The product is indicated for the treatment of erectile dysfunction (ED) in adult men and for pulmonary arterial hypertension (PAH) in patients of any gender. Tablets are supplied in strips of 10, with pack sizes of 60, 90, or 120 tablets to suit short‑term or long‑term therapy needs.

nn

What is Tadaflo 20 mg

n

Tadaflo 20 mg belongs to the class of PDE‑5 inhibitors that enhance the cyclic guanosine monophosphate (cGMP) pathway in the vascular endothelium. By blocking PDE‑5, the drug promotes smooth‑muscle relaxation in the corpus cavernosum of the penis and in the pulmonary vasculature, facilitating increased blood flow. The therapeutic effect requires sexual stimulation for ED and physiological vasodilation for PAH. The formulation is bioequivalent to reference Tadalafil products and meets the quality standards set by the Central Drugs Standard Control Organization (CDSCO) in India.

nn

Uses and Benefits

n

Primary uses of Tadaflo 20 mg are the improvement of erectile function and the management of pulmonary arterial hypertension. Clinical studies show statistically significant improvements in erection rigidity and duration, as well as increased exercise capacity and reduced PAH progression. Reported benefits include:

n

n
• Enhanced sexual confidence and satisfaction

n

• Improved exercise tolerance in PAH patients

n

• Convenient once‑daily dosing for most indications

n

• Long duration of action – up to 36 hours

n

n

These outcomes contribute to a better quality of life when the medication is used under medical supervision.

nn

How It Works

n

Tadalafil, the active component of Tadaflo, selectively blocks the PDE‑5 enzyme that degrades cGMP. When cGMP levels rise, nitric‑oxide‑mediated vasodilation occurs, leading to smooth‑muscle relaxation. In penile tissue this results in engorgement of erectile tissue, while in the pulmonary arteries it reduces vascular resistance. The pharmacokinetic profile features rapid absorption with a median time to maximum concentration of approximately 2 hours and a prolonged half‑life of about 17.5 hours, supporting a sustained therapeutic effect.

nn

Dosage Guidelines

n

Dosage should always be individualized by a qualified healthcare professional. For erectile dysfunction, a common starting dose is one 20 mg tablet taken as needed, approximately 30 minutes to 2 hours before anticipated sexual activity. The effect may last up to 36 hours, allowing flexibility in timing. For pulmonary arterial hypertension, a daily regimen is typically prescribed, using the same 20 mg strength under medical direction. Patients are advised not to exceed one tablet per day and to avoid use with nitrates or alpha‑blockers that could cause hypotensive events. Adjustments may be necessary for patients with hepatic impairment or those taking strong CYP3A4 inhibitors. Always consult a physician for personalized dosing recommendations.

nn

Side Effects

n

Like all pharmaceutical agents, Tadaflo 20 mg may be associated with adverse effects. Most reactions are mild and transient, but patients should be aware of the full spectrum of possible outcomes:

n

n
• Headache

n

• Flushing

n

• Indigestion or dyspepsia

n

• Back pain or myalgia

n

• Nasal congestion

n

• Dizziness

n

n

Rare but serious complications include sudden vision loss, hearing impairment, or priapism lasting more than four hours. In such cases, immediate medical attention is required. Patients with cardiovascular instability should discuss potential risks with their clinician before initiating therapy.

nn

Warnings and Precautions

n

Before prescribing Tadaflo 20 mg, clinicians should evaluate cardiovascular status, as sexual activity may pose a risk for individuals with uncontrolled hypertension, angina, or recent myocardial infarction. Concomitant use with nitric‑oxide donors, nitrates, or certain anti‑fibrotic agents is contraindicated due to the potential for severe hypotension. Patients with severe renal or hepatic impairment may require dose modification. Excessive alcohol consumption should be avoided, as it can exacerbate dizziness and increase the likelihood of side effects. Pregnant or breastfeeding women should not use this medication, as safety data are insufficient.

nn

Frequently Asked Questions

n

Q: Can Tadaflo 20 mg be taken with food?
A: Tadalafil is not significantly affected by food; however, a high‑fat meal may delay the onset of action slightly. Patients may take the tablet with or without meals as convenient.

nn

Q: How long does the effect of Tadaflo last?
A: The pharmacologic effect can persist for up to 36 hours, which is why it is sometimes referred to as a “weekend pill.” Duration may vary based on individual metabolism and dosage.

nn

Q: Is Tadaflo safe for patients with diabetes?
A: Clinical data indicate that Tadalafil can be used safely in men with diabetes mellitus, provided that cardiovascular status is stable and no contraindicated medications are being used.

nn

Q: Where can I find the official prescribing information?
A: The full FDA‑approved prescribing information is available at the U.S. Food and Drug Administration’s drug label repository: FDA Label. Additional details can be reviewed on MedlinePlus: MedlinePlus.

nn

Q: What should I do if I miss a dose for PAH?
A: For pulmonary arterial hypertension, Tadaflo is usually taken daily. If a dose is missed, the patient should take it as soon as remembered unless it is close to the time of the next scheduled dose; in that case, the missed dose should be skipped and the dosing schedule resumed.

nn

Q: Are there any dietary restrictions?
A: No specific dietary restrictions are required. Patients should avoid excessive grapefruit juice, which can increase plasma concentrations of Tadalafil and potentially heighten side effects.

nn

Regulatory and Quality Assurance

n

Cipla Limited adheres to Good Manufacturing Practices (GMP) as defined by the WHO and the Indian Central Drugs Standard Control Organization. Each batch of Tadaflo undergoes rigorous identity, purity, and potency testing, with certificates of analysis provided for regulatory compliance. The product is also listed on the Drugs.com database, which aggregates FDA‑verified safety data and patient‑reported experiences: Drugs.com – Tadafil. For comprehensive clinical‑trial data, refer to the NIH’s PubMed database: PubMed – Tadalafil.

nn

Customer Support and Ordering Information

n

When purchasing Tadaflo 20 mg online, customers can expect secure payment processing, discreet packaging, and tracking information. Shipping typically occurs within 6 to 15 business days, depending on destination and customs clearance. Our platform offers multiple pack sizes to accommodate individual treatment plans, and a dedicated support team is available to answer clinical or logistical questions. For further assistance, please consult our ordering FAQs or contact a licensed pharmacist.

n